Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1964 Apr;27(2):96–99. doi: 10.1136/jnnp.27.2.96

Serum enzyme studies in muscle disease

Part II Serum creatine kinase activity in muscular dystrophy and in other myopathic and neuropathic disorders

John M S Pearce 1,1, R J Pennington 1, John N Walton 1
PMCID: PMC495703  PMID: 14167093

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AEBI U., RICHTERICH R., COLOMBO J. P., ROSSI E. Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive sex-linked juvennile (Duchenne) type by serum creatine-phosphokinase determinations. Epilepsia. 1961;1:61–74. [PubMed] [Google Scholar]
  2. DREYFUS J. C., SCHAPIRA G., DEMOS J. Etude des différences artérioveineuses au cours des myopathies. 1. Oxygène, glucose et acide lactique. 2. Aldolase plasmatique. Clin Chim Acta. 1958 Nov;3(6):571–577. doi: 10.1016/0009-8981(58)90010-x. [DOI] [PubMed] [Google Scholar]
  3. DREYFUS J. C., SCHAPIRA G. [Biochemistry of progressive muscular dystrophy]. Klin Wochenschr. 1962 Apr 15;40:373–379. doi: 10.1007/BF01732835. [DOI] [PubMed] [Google Scholar]
  4. GRAIG F. A., ROSS G. Serum creatine-phosphokinase in thyroid disease. Metabolism. 1963 Jan;12:57–59. [PubMed] [Google Scholar]
  5. GRIFFITHS P. D. Creatinephosphokinase levels in hypothyroidism. Lancet. 1963 Apr 20;1(7286):894–894. doi: 10.1016/s0140-6736(63)91676-3. [DOI] [PubMed] [Google Scholar]
  6. HUGHES B. P. Serum enzymes in carriers of muscular dystrophy. Br Med J. 1962 Oct 13;2(5310):963–964. doi: 10.1136/bmj.2.5310.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. PEARSON C. M., CHOWDHURY S. R., FOWLER W. M., Jr, JONES M. H., GRIFFITH W. H. Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons. Pediatrics. 1961 Dec;28:962–970. [PubMed] [Google Scholar]
  8. PEARSON C. M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med. 1957 Jun 6;256(23):1069–1075. doi: 10.1056/NEJM195706062562301. [DOI] [PubMed] [Google Scholar]
  9. Richterich R., Rosin S., Aebi U., Rossi E. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet. 1963 Jun;15(2):133–154. [PMC free article] [PubMed] [Google Scholar]
  10. THOMPSON R. A., VIGNOS P. J., Jr Serum aldolase in muscle disease. AMA Arch Intern Med. 1959 Apr;103(4):551–564. doi: 10.1001/archinte.1959.00270040037004. [DOI] [PubMed] [Google Scholar]
  11. THOMSON W. A. Sources of error in the biochemical diagnosis of muscular dystrophy. J Neurol Neurosurg Psychiatry. 1962 Aug;25:191–202. doi: 10.1136/jnnp.25.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. THOMSON W. H., LEYBURN P., WALTON J. N. Serum enzyme activity in muscular dystrophy. Br Med J. 1960 Oct 29;2(5208):1276–1281. doi: 10.1136/bmj.2.5208.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WALTON J. N., NATTRASS F. J. On the classification, natural history and treatment of the myopathies. Brain. 1954;77(2):169–231. doi: 10.1093/brain/77.2.169. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES